Literature DB >> 10965193

Prostacyclin deficiency and reduced fetoplacental blood flow in pregnancy-induced hypertension and preeclampsia.

W Klockenbusch1, T W Goecke, J S Krüssel, B A Tutschek, G Crombach, K Schrör.   

Abstract

BACKGROUND: Low endothelial generation of prostacyclin (PGI(2)) is a typical feature of pregnancy-induced hypertensive disorders. The aim of the current study was to establish whether changes in PGI(2) are accompanied by alterations in fetoplacental blood flow and to test the hypothesis that PGI(2) deficiency contributes to reduced fetoplacental perfusion in pregnancy-induced hypertension (PIH) and preeclampsia.
METHODS: The study included 11 women with normal pregnancies, 12 with PIH/preeclampsia, and 7 with otherwise complicated pregnancies. Fetoplacental blood flow was assessed both by umbilical artery Doppler sonography measuring the resistance index (RI) and by means of neonatal birth weight. PGI(2) formation was measured in umbilical arteries prepared immediately after birth. PGI(2), RI and birth weight were correlated with and without correction for gestational age. Furthermore, data from patients with PIH/preeclampsia were compared with normal pregnancies as controls.
RESULTS: A significant inverse correlation was found between umbilical PGI(2) formation and umbilical RI and between birth weight and RI, whereas PGI(2) and birth weight were directly related. Patients with PIH/preeclampsia showed reduced PGI(2) formation, markedly increased gestational age-corrected RI and significantly reduced percentile birth weight.
CONCLUSIONS: These results provide evidence showing that PGI(2) is a relevant mediator of fetoplacental blood flow and suggest an important role of PGI(2) deficiency in PIH/preeclampsia. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10965193     DOI: 10.1159/000010292

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  4 in total

1.  Decidual Cox2 inhibition improves fetal and maternal outcomes in a preeclampsia-like mouse model.

Authors:  Jenny L Sones; Jeeyeon Cha; Ashley K Woods; Amanda Bartos; Christa Y Heyward; Heinrich E Lob; Catherine E Isroff; Scott D Butler; Stephanie E Shapiro; Sudhansu K Dey; Robin L Davisson
Journal:  JCI Insight       Date:  2016-03-17

2.  Vitamin E: maternal concentrations are associated with fetal growth.

Authors:  Theresa O Scholl; Xinhua Chen; Melissa Sims; T Peter Stein
Journal:  Am J Clin Nutr       Date:  2006-12       Impact factor: 7.045

3.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

4.  Histomorphometry of umbilical cord blood vessels in preeclampsia.

Authors:  Manuel V Blanco; Hilda R Vega; Rodolfo Giuliano; Daniel R Grana; Francisco Azzato; Jorge Lerman; Jose Milei
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-11-04       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.